COPENHAGEN (AFX) - Novo Nordisk AS said it has formed a partnership with French biopharmaceutical company Innate Pharma SA, to develop new drugs to support what are called ‘natural killer’ (NK) cells, one of the body’s first lines of defence against cancer cells and infections.
